Lifera Enters into Strategic Collaboration with CENTOGENE

Lifera Enters into Strategic Collaboration with CENTOGENE

CENTOGENE and Lifera announced a strategic collaboration with the establishment of a joint venture (JV) to improve patient access to quality multiomics locally and regionally in Saudi Arabia and the Gulf Cooperation Council (GCC). Under the terms of the collaboration, CENTOGENE will receive a $30 million mandatory convertible loan from Lifera. This partnership will not only facilitate biopharma research in rare diseases but also support collaborative research initiatives in Saudi Arabia and with global partners. This strategic collaboration aligns with Lifera's mission to foster the growth of Saudi Arabia's biopharma sector. Leveraging CENTOGENE's expertise in rare, metabolic, and neurodegenerative diseases, the joint venture aims to deliver timely and accurate diagnoses that are crucial for patients and their families. The JV will establish an advanced laboratory and bioinformatics infrastructure, leveraging the CENTOGENE Biodatabank. This biodatabank is the world's largest integrated multiomic data repository in rare disease biobanks and neurodegenerative diseases, encompassing more than 70 million datasets, including over 35,000 from Saudi Arabian patients. By working closely with CENTOGENE globally, the joint venture will develop genetic testing and interpretation capabilities, acting as a platform for large-scale national screening and genomics programmes.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!